Ch. Fleck

755 total citations
78 papers, 652 citations indexed

About

Ch. Fleck is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Clinical Biochemistry. According to data from OpenAlex, Ch. Fleck has authored 78 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pediatrics, Perinatology and Child Health, 23 papers in Oncology and 21 papers in Clinical Biochemistry. Recurrent topics in Ch. Fleck's work include Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (22 papers) and Metabolism and Genetic Disorders (21 papers). Ch. Fleck is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (22 papers) and Metabolism and Genetic Disorders (21 papers). Ch. Fleck collaborates with scholars based in Germany, Czechia and France. Ch. Fleck's co-authors include H Bräunlich, Martin Busch, G Stein, G Wolf, Markus Schwertfeger, Dorothea Appenroth, G Stein, Peter M. Taylor, J Heller and Frans Marx and has published in prestigious journals such as Pharmacology & Therapeutics, Toxicology and Pflügers Archiv - European Journal of Physiology.

In The Last Decade

Ch. Fleck

77 papers receiving 640 citations

Peers

Countries citing papers authored by Ch. Fleck

Since Specialization

Citations

This map shows the geographic impact of Ch. Fleck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. Fleck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. Fleck more than expected).

Fields of papers citing papers by Ch. Fleck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ch. Fleck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. Fleck. The network helps show where Ch. Fleck may publish in the future.

Co-authorship network of co-authors of Ch. Fleck

This figure shows the co-authorship network connecting the top 25 collaborators of Ch. Fleck. A scholar is included among the top collaborators of Ch. Fleck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ch. Fleck. Ch. Fleck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Microenvironmental pH-Modulated Dissolution of Albendazole Layered on Tartaric Acid Starter Pellet Cores 2025 ·Pharmaceutics ·(unknown), Miléna Lengyel, Ch. Fleck, Nikolett Kállai‐Szabó, (unknown), András József Laki, István Antal	0
2	In vivo investigations on the cholinesterase-inhibiting effects of tricyclic quinazolinimines: Scopolamine-induced cognitive impairments in rats are attenuated at low dosage and reinforced at higher dosage 2007 ·Pflügers Archiv - European Journal of Physiology ·Dorothea Appenroth, Michael Decker, Christian Tränkle, (unknown), J. Lehmann, Ch. Fleck	6
3	Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease – possible candidates for paradoxical epidemiology? 2006 ·Amino Acids ·Martin Busch, Ch. Fleck, G Wolf, G Stein	59
4	Ex vivo stimulation of renal transport of the cytostatic drugs methotrexate, cisplatin, topotecan (Hycamtin) and raltitrexed (Tomudex) by dexamethasone, T3 and EGF in intact human and rat kidney tissue and in human renal cell carcinoma 2002 ·Urological Research ·Ch. Fleck, Ralf A. Hilger, (unknown), E. Karge, (unknown), (unknown), J. Schubert	12
5	Renal amino acid transport in immature and adult rats during chromate and cisplatinum-induced nephrotoxicity 2001 ·Amino Acids ·Ch. Fleck, (unknown), (unknown), Dorothea Appenroth	11
6	Ex vivo stimulation of renal tubular p -aminohippurate transport by dexamethasone and triiodothyronine in human renal cell carcinoma 2000 ·Urological Research ·Ch. Fleck, (unknown), (unknown), E. Karge, (unknown), J. Schubert	6
7	In vitro stimulation of renal tubular p -aminohippurate transport by dexamethasone in rat kidneys and in intact kidney tissue of patients suffering from renal cell carcinoma 1998 ·Urological Research ·Ch. Fleck, (unknown), (unknown), (unknown), J. Schubert	3
8	Influence of vitamin E treatment on glutathione system after renal ischemia in immature and adult rats 1997 ·Experimental and Toxicologic Pathology ·Ch. Fleck, (unknown), (unknown), H Bräunlich	4
9	In vitro stimulation of renal tubular p-aminohippurate transport by dexamethasone in kidney tissue of immature and adult rats 1997 ·Experimental and Toxicologic Pathology ·Ch. Fleck	3
10	Influence of triiodothyronine and dexamethasone on renal amino acid handling in rats loaded with various amino acid mixtures 1996 ·Amino Acids ·Ch. Fleck, (unknown)	3
11	Age-dependent differences in the effect of ischaemia on the rat kidney: prevention of the postischaemic damage by different drugs 1993 ·Experimental and Toxicologic Pathology ·Ch. Fleck, J Heller	11
12	Age dependent different consequences of bilateral nephrectomy (NX) in rats 1993 ·Experimental and Toxicologic Pathology ·(unknown), H Bräunlich, Ch. Fleck, M. Hohenegger, Michael Kretzschmar, Haiko Sprott	6
13	Evaluation of methods indicating higher susceptibility of immature rats to renal ischemia 1993 ·Experimental and Toxicologic Pathology ·Ch. Fleck, (unknown), (unknown), (unknown), Martin Möckel, H Bräunlich	2
14	Influence of vasoactive substances on uremic bleeding in rats 1991 ·Experimental Pathology ·Haiko Sprott, Ch. Fleck, H Bräunlich	1
15	Relation between renal and hepatic excretion of drugs: XIV. Elimination of ioglycamic acid after nephrectomy, bile duct ligation, and after treatment with hormones or xenobiotics in young and adult rats 1991 ·Experimental Pathology ·Ch. Fleck, (unknown), Adam D. Linstedt, Ulf Linstedt, (unknown), H Bräunlich	4
16	Influence of xenobiotics on bile flow and bile composition in rats — Methodological approach 1990 ·Experimental Pathology ·Ch. Fleck, (unknown)	16
17	Relation between renal and hepatic excretion of drugs: XIII. Pharmacokinetics of new antiarrhythmic drug Bonnecor® in rats with normal and impaired excretory functions 1989 ·Experimental Pathology ·Ch. Fleck, Stefan Richter, (unknown), (unknown), H Bräunlich	5
18	Relation between renal and hepatic excretion in drugs 1988 ·Experimental Pathology ·Ch. Fleck, (unknown), H Bräunlich	6
19	Relation between renal and hepatic excretion of drugs: VII. Hepatic and renal excretion of phenol red in thioacetamide-induced a cute and chronic liver damage 1988 ·Experimental Pathology ·Ch. Fleck, Thomas Zimmermann, H Franke, H Bräunlich, R. Dargel	5
20	Renal blood flow after stimulation of p-aminohippurate transport. 1981 ·PubMed ·Ch. Fleck, (unknown), (unknown), (unknown), H Bräunlich	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact